With new technology and new drugs changing diabetes treatment at an unprecedented pace, the Endocrine Society’s “Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Guideline” looks through the latest evidence on glycemic control for the most comprehensive guidance on selecting the optimal approach in hospitalized patients. The practice of...
Last summer, the U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes and in adults with type 2 diabetes. The FDA granted approval for insulin glargine-yfgn to Mylan Pharmaceuticals Inc., who is marketing the product as Semglee. Semglee...
Black People with Diabetes Disproportionately Affected by Diabetic Ketoacidosis During COVID
Black people with diabetes were more likely to develop cases of a life-threatening complication called diabetic ketoacidosis during the pandemic, even in people without COVID-19, according to a new study from the T1D Exchange published in The Journal of Clinical Endocrinology and Metabolism. People with diabetes are more likely to get extremely sick from COVID-19,...
People with Diabetes Who Eat Less Processed Food at Night May Live Longer
Study finds eating carbs earlier in the day is linked to better heart health. The time of day that people with diabetes eat certain foods may be just as important to their well-being as portion size and calories, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology and Metabolism. Mealtimes...
Strategic Partnership Will Bring Digital Health Innovation to the Hospital Bedside
Glytec and Roche Diagnostics USA last month announced a digital health collaboration that combines Roche’s expertise in medical devices and IT solutions with Glytec’s FDA-cleared insulin dosing decision support software, Glucommander™, to address the pervasive challenges with inpatient blood sugar management at the hospital bedside. Glucommander will be the first software application available to run...
Newly Identified Hormone May Be Critical Driver of Type 1 and Type 2 Diabetes
A newly discovered hormone named fabkin helps regulate metabolism and may play an important role in the development of both type 1 and type 2 diabetes, according to research led by the Sabri Ülker Center for Metabolic Research at Harvard T.H. Chan School of Public Health. The findings were published in Nature. The study showed blood...
The U.S. Food and Drug Administration (FDA) last month approved a rechargeable neurostimulator and a recharge-free neurostimulator for the treatment of chronic pain associated with diabetic peripheral neuropathy (DPN). Medtronic is marketing the products as Intellis™ and Vanta™, respectively. DPN is a debilitating and progressive neurological disorder that affects approximately 30% of people with diabetes,...
Obesity Is More Prevalent in People with Type 1 Diabetes than Previously Thought
People with type 1 diabetes should be screened regularly for obesity and chronic kidney disease, according to a study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Almost half of the adults in the U.S. have obesity, a chronic progressive disease characterized by an individual having an excess of body fat. Obesity is one of...
